Ariad Pharmaceuticals Inc (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

2
Player Avatar shaneatlas (77.30) Submitted: 10/9/2013 2:24:26 PM : Outperform Start Price: $5.24 ARIA Score: -3.14

oversold

Featured Broker Partners


Advertisement